Article
Association of common genetic variants with risperidone adverse events in a Spanish schizophrenic population.
The pharmacogenomics journal - 1 Apr 2013
Almoguera B, Riveiro-Alvarez R, Lopez-Castroman J, Dorado P, Vaquero-Lorenzo C, Fernandez-Piqueras J, Llerena A, Abad-Santos F, Baca-García E, Dal-Ré R, Ayuso C
Abstract excerpt
Risperidone non-compliance is often high due to undesirable side effects, whose development is in part genetically determined. Studies with genetic variants involved in the pharmacokinetics and pharmacodynamics of risperidone have yielded inconsistent results. Thus, the aim of this study was to investigate the putative association of genetic markers with the occurrence of four frequently observed adverse events...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
